APM
NAUT icon

Avidity Partners Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Avidity Partners Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-600,000
Closed -$3.68M – 106
2021
Q3 		$3.68M Sell
600,000
-525,000
-47% -$4.18M 0.08% 95
2021
Q2 		$11.4M Buy
1,125,000
+625,000
+125% +$6.77M 0.31% 66
2021
Q1 		$6.89M Hold
500,000
– – 0.19% 79
2020
Q4 		$5.42M Buy
+500,000
New +$5.27M 0.18% 77

Other funds holding NAUT

Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
AEPBI
AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Amazon.com Inc
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Avidity Partners Management's NAUT Position: Q4 2021 in Review

Avidity Partners Management sold out of Nautilus Biotechnolgy (NAUT) in Q4 2021, closing a stake of 600,000 shares — an estimated $3.68M sold.

Avidity Partners Management first reported a position in NAUT in Q4 2020 and held it in 4 quarters. The position peaked at $11.4M in Q2 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q4 2021.

  • Avidity Partners Management reported no remaining Nautilus Biotechnolgy position as of Q4 2021 after selling out during the quarter.
  • Avidity Partners Management sold 600,000 Nautilus Biotechnolgy shares in Q4 2021, an estimated $3.68M.
  • Avidity Partners Management first reported a position in Nautilus Biotechnolgy in Q4 2020 and held it in 4 quarters.
  • Avidity Partners Management's Nautilus Biotechnolgy position peaked at $11.4M in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2021.

Based on Avidity Partners Management's 13F filing for Q4 2021, filed 14 Feb 2022.